Middletown, DE -- (SBWIRE) -- 10/03/2013 -- VipStockReports.com screens the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way. Today our focus is on: MannKind Corporation(NASDAQ:MNKD), Geron Corporation (NASDAQ:GERN), First Niagara Financial Group Inc.(NASDAQ:FNFG), Nektar Therapeutics (NASDAQ:NKTR)
MannKind Corporation(NASDAQ:MNKD) was a volume gainer of 2.34 million shares and the average volume of the stock remained 5.70 million shares. The stock opened the session at $5.67 and finished at the end of the day at $5.75 and the stock escalated +1.39%.The market capitalization of the stock remained 1.74 billion. The half-yearly trend of the stock remained positive +51.72%. MannKind Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic products for diabetes and cancer in the United States. MannKind Corporation was founded in 1991 and is headquartered in Valencia, California.
For How Long MNKD will fight for Profitability? Read This Trend Analysis report
In the preceding trading session, Geron Corporation (NASDAQ:GERN) exchanged 2.31 million shares and the average volume remained 1.83 million shares. The stock closed the session at $3.40 with the gain of +2.41%. Tracking three months and 6 months trends, the stock was at of +129.73% and +203.57%, respectively. Geron Corporation is a clinical stage biopharmaceutical company developing a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. The company was founded in 1990 and is based in Menlo Park, California.
Will GERN Continue To Move Higher? Find Out Here
First Niagara Financial Group Inc.(NASDAQ:FNFG) decreased -0.19% and its closing price was $10.42. The volume of the stock was 2.24 million shares and the average volume remained 3.53 million shares. Yesterday, the stock traded amid the day price range of $10.35 - $10.49. The market capitalization of the stock remained 3.83 billion. The beta of the stock remained 0.81. First Niagara Financial Group, Inc. operates as the bank holding company for First Niagara Bank, N.A. that provides retail and commercial banking, and other financial services to individuals, families, and businesses. First Niagara Financial Group, Inc. was founded in 1870 and is headquartered in Buffalo, New York.
Will FNFG Get Buyers Even After The Recent Rally? Find Out Here
Nektar Therapeutics (NASDAQ:NKTR) exchanged 2.25 million shares in the previous trading session, and its average trading remained 1.47 million shares. NKTR dropped -144% and it closed the trading at $10.30. The market capitalization of the stock remained 1.19 billion. YTD trend of the stock was positive +45.48%. Nektar Therapeutics, a clinical-stage biopharmaceutical company, engages in developing a pipeline of drug candidates that utilize its PEGylation and polymer conjugate technology platforms. Its product pipeline consists of drug candidates in various therapeutic areas, including oncology, pain, anti-infectives, and immunology.
Has NKTR Found The Bottom and Ready To Move Up? Find Out Here
We screen the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Once we find the 'Next Hot Penny Stock' with Monster Upside Potential we immediately Email it to you in our detailed VIP Report so you can Beat Rest of the Crowd!!
Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way.
VipstockReports.com newsletters and website: The disclaimer is to be read entirely and fully understood before using our website, or joining our newsletter email list. Never invest into a stock discussed on this website or the Vipstockalerts.com newsletter unless you can afford to lose your entire investment. Please consult with a certified financial advisor before making any investment decisions.
VipStockReports.com and any affiliates and information providers make no implied or express warranties on the information provided. Please verify quotes with your financial advisor before making investment decisions. This is not to be construed as a solicitation to buy or sell securities. As with any stock, the featured companies profiled on the VipstockReports.com web site and/or newsletter involve a high degree of volatility and risk, and all investors should know that they may lose a portion of or all of their investment if they decide to purchase any stocks.
Read Full Disclaimer at: http://www.vipstockreports.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)